Pre-Clinical QT Prolongation Guidance Urges In Vitro, In Vivo Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's 1draft guidance on preclinical evaluation of QT prolongation urges drug companies to initiate follow-up studies when nonclinical studies are inconsistent